GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024Business Wire • 11 days ago
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access...
Share to Feed
HC Wainwright restated their buy rating on shares of GlycoMimetics (NASDAQ:GLYC - Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a...
GlycoMimetics, Inc. (NASDAQ:GLYC - Free Report) - HC Wainwright issued their FY2026 EPS estimates for shares of GlycoMimetics in a report issued on Wednesday, March 27th. HC Wainwright analyst E...
This is a signal that GLYC's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX Research Report), GlycoMimetics...
Related Stocks: NAS:GLYC...
GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript March 27, 2024
GlycoMimetics, Inc. isnt one of the 30 most popular stocks among hedge funds at the end of the third quarter...
GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its...
GLYC Advances Clinical Programs Despite Reporting Expected LossesRelated Stocks: GLYC...
GlycoMimetics, Inc. (GLYC) Q4 2023 Earnings Call Transcript...